Tuberculosis and the Heart
Why the study?
Tuberculosis remains poorly controlled globally and can involve the heart, prompting a review to advance algorithms for diagnosing and managing cardiovascular complications.
Design
Systematic review
Authors
Discussion
Loading...
Member takes
Implication
Supports early cardiac screening in TB patients, especially with AIDS; reinforces combined chemotherapy plus corticosteroids to improve hard outcomes.
Key Points
- Summarize the cardiovascular manifestations of tuberculosis and outline diagnostic and therapeutic algorithms for clinical practice.
- Conducted a systematic review under the NET-Heart Project initiative organized by the Interamerican Society of Cardiology.
- Assessed cardiovascular manifestations, diagnostic strategies including echocardiography and biomarker testing, and therapeutic interventions.
- Pericardial involvement is the most common cardiac complication, particularly among patients with HIV/AIDS, and represents the leading etiology of constrictive pericarditis in endemic areas.
- Myocarditis and aortitis caused by tuberculosis occur rarely and present with systemic symptoms differing from standard bacterial or viral infections.
- Treatment combining antituberculosis chemotherapy and corticosteroids significantly reduces mortality, pericardial constriction, and hospital admissions.
Structured PICO
P
Population
Patients with tuberculosis, particularly those with or at risk for cardiovascular involvement such as pericarditis, myocarditis, or aortitis.
Tuberculosis frequently involves the heart, most commonly causing pericarditis, and requires early detection and treatment with antituberculosis chemotherapy and corticosteroids to prevent heart failure, constrictive pericarditis, and death.
Cite This Study
López-López et al. (2021) studied this question.